Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Ning J et al. | 1992 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), Daudi (Burkitt's lymphoma cell line) cells and normal human lymphocytes | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.1 mT |
Falone S et al. | 2008 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 0.1 mT |
Fedrowitz M et al. | 2012 | animal, rat/Fischer 344 and Lewis, whole body | magnetic field, low frequency, 50/60 Hz | 100 µT |
Kabacik S et al. | 2013 | animal, mouse/C57BL/6, whole body | magnetic field, 50/60 Hz | 100 µT |
Manzella N et al. | 2015 | intact cell/cell culture, HuDe cells (human dermal fibroblasts) | magnetic field, 50/60 Hz | 0.1 mT |
Miyata H et al. | 2015 | intact cell/cell culture, human umbilical vein endothelial cells (HUVEC) | magnetic field, 50/60 Hz | 100 µT |
Luukkonen J et al. | 2017 | intact cell/cell culture, human neuroblastoma cell line (SH-SY5Y) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Zhou L et al. | 2016 | animal, rat/Sprague Dawley, whole body | magnetic field, 50/60 Hz | 100 µT |
Martínez MA et al. | 2021 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | 50/60 Hz, magnetic field | 100 µT |
Zhang Y et al. | 2020 | animal, rat/Sprague Dawley, whole body | 50/60 Hz, magnetic field | 100–500 µT |
Zhou J et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 0.1–0.8 mT |
Pipkin JL et al. | 1999 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 100 µT–1 mT |
Zhu H et al. | 2016 | intact cell/cell culture, human fetal scleral fibroblasts | magnetic field, 50/60 Hz | 0.1–1 mT |
Lee HC et al. | 2015 | intact cell/cell culture, MCF10 A (human breast epithelial cell line), MCF7 (human breast cancer cell line), Jurkat cells (human lymphoblastoid T cell line), NIH3T3 (mouse embryonic fibroblast cell line) | magnetic field, 50/60 Hz | 0.1–2 mT |
Czyz J et al. | 2004 | intact cell/cell culture, D3 (murine embryonic stem cell line, p53-deficient and wild type) | magnetic field, 50/60 Hz, power transmission line | 100 µT–2.3 mT |
Zhou J et al. | 2019 | intact cell/cell culture, rat calvarial osteoblasts, rat/Sprague Dawley, animal, whole body | magnetic field, 50/60 Hz | 0.1–2.4 mT |
Li H et al. | 2018 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 0.1–2.5 mT |
Li Y et al. | 2014 | intact cell/cell culture, dorsal root ganglion neurons (rat/Sprague-Dawley) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 0.1–100 mT |
Potenza L et al. | 2012 | intact cell/cell culture, truffle mycelium <i>Tuber borchii</i> | magnetic field, static magnetic field, 50/60 Hz, DC | 0.1–300 mT |
Wang J et al. | 2013 | intact cell/cell culture, human fetal scleral fibroblasts and retinal pigment epithelial cells | magnetic field, 50/60 Hz, co-exposure | 0.2 mT |
Zhu H et al. | 2013 | intact cell/cell culture, human fetal scleral fibroblasts | magnetic field, 50/60 Hz, co-exposure | 0.2 mT |
Mustafa E et al. | 2021 | intact cell/cell culture, murine FDC-P1 (factor-dependent continuous - Paterson 1) hematopoietic cells | magnetic field, 50/60 Hz, co-exposure | 200 µT |
Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
Aalami Zavareh F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, low frequency | 0.2–2 mT |
Heidari S et al. | 2021 | intact cell/cell culture, human adenocarcinoma gastric cancer cell line (AGS) | 50/60 Hz, magnetic field | 0.2–2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.